American Well Corporation (AMWL)
| Market Cap | 210.06M +155.5% |
| Revenue (ttm) | 211.23M -20.3% |
| Net Income | -57.10M |
| EPS | -3.42 |
| Shares Out | 17.01M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 181,783 |
| Open | 12.59 |
| Previous Close | 12.74 |
| Day's Range | 11.80 - 13.81 |
| 52-Week Range | 3.71 - 15.16 |
| Beta | 1.69 |
| Analysts | Hold |
| Price Target | 13.20 (+6.88%) |
| Earnings Date | Nov 3, 2026 |
About AMWL
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into th... [Read more]
Financial Performance
In 2025, American Well's revenue was $249.33 million, a decrease of -1.98% compared to the previous year's $254.36 million. Losses were -$95.70 million, -54.02% less than in 2024.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for AMWL stock is "Hold." The 12-month stock price target is $13.2, which is an increase of 6.88% from the latest price.
News
Amwell Says One-Third of Adults Now Using AI Health Tools
American Well Corp. (Amwell) says is seeing a fundamental evolution in how corporate buyers and consumers navigate digital medicine.
Amwell price target raised to $13 from $12 at TD Cowen
TD Cowen raised the firm’s price target on Amwell (AMWL) to $13 from $12 and keeps a Hold rating on the shares. The company delivered a 3Q beat and raise…
Amwell price target raised to $12 from $11 at Stifel
Stifel analyst David Grossman raised the firm’s price target on Amwell (AMWL) to $12 from $11 and keeps a Hold rating on the shares.
American Well Earnings Call Transcript: Q3 2026
Q3 revenue exceeded guidance and adjusted EBITDA loss narrowed sharply as costs fell. FY 2026 guidance rose, with Q4 break-even to positive adjusted EBITDA targeted; VA and DHA contract timing remains a key 2027 growth variable.
American Well Earnings release: Q3 2026
American Well released its Q3 2026 earnings on November 3, 2026, summarizing the period's financial results.
American Well Quarterly report: Q3 2026
American Well has published its Q3 2026 quarterly earnings report on November 3, 2026.
Amwell reports Q3 EPS (67c), consensus (66c)
Reports Q3 revenue $48.99M, consensus $47.29M. “Health plans and employers want engagement, outcomes and proof, and Amwell’s (AMWL) single platform is built to deliver all three,” said Ido Schoenberg,...
Amwell® Announces Results for the Third Quarter 2026
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the thir...
Amwell® to report third quarter 2026 operating results
BOSTON, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL a leading provider of technology-enabled care, will report third quarter 2026 operating results after stock market trading hours on Tuesd...
Discovery Health expanded access to mental healthcare for 22,000 members in one year, with better outcomes and lower hospital costs
BOSTON and JOHANNESBURG, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology-enabled care, today published a new case study on Discovery Health's use of SilverClou...
American Well Transcript: Morgan Stanley 24th Annual Global Healthcare Conference
The company has pivoted to focus on government and payer markets, securing major contracts with the DHA and VA while enhancing its SaaS platform and organizational discipline. Improved financial stability, renewed growth prospects, and AI-driven efficiency are central to its strategy.
Amwell gets LOI from Department of Veterans Affairs for virtual health platform
Amwell (AMWL) announced the Department of Veterans Affairs has declared its intent for the company to deploy its virtual health platform within the VA enterprise and help power the modernization…
Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure
BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced the Department of Veterans A...
Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation
BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, has received Frost & Sullivan's 2026 United States Technology Innovation Leadership Reco...
Amwell® to participate in upcoming investor conferences
BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, today announced that members of the Amwell management team will participate in the follo...
Amwell price target raised to $12 from $7.50 at Truist
Truist raised the firm’s price target on Amwell (AMWL) to $12 from $7.50 and keeps a Hold rating on the shares. The firm is updating its model after the company’s…
Amwell makes grant to new employees under inducement plan
BOSTON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announces that on August 7, Amwe...
Amwell price target raised to $13 from $6.50 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Amwell (AMWL) to $13 from $6.50 and keeps an Equal Weight rating on the shares. Revenue estimates have been stabilizing and management…
Amwell price target raised to $12 from $8 at TD Cowen
TD Cowen raised the firm’s price target on Amwell (AMWL) to $12 from $8 and keeps a Hold rating on the shares. The firm said 2Q rev/adj. EBITDA beat driven…
Amwell price target raised to $11 from $6.50 at Stifel
Stifel raised the firm’s price target on Amwell (AMWL) to $11 from $6.50 and keeps a Hold rating on the shares. Q2 revenue and EBITDA beat on stronger-than-expected subscription revenue…
American Well Earnings Call Transcript: Q2 2026
Q2 2026 saw sequential subscription revenue growth and improved margins, with a major DHA contract milestone and strong cash position. Guidance was raised for full-year revenue and EBITDA, and the company remains on track for breakeven in Q4 and double-digit growth in 2027 if pipeline contracts close.
American Well Earnings release: Q2 2026
American Well released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
American Well Quarterly report: Q2 2026
American Well has published its Q2 2026 quarterly earnings report on August 4, 2026.
Amwell reports Q2 EPS (59c), consensus (60c)
Reports Q2 revenue $52.05M, consensus $49.88M. “The DHA’s intent to make Amwell (AMWL) a prime contractor is a powerful endorsement of our platform and our people,” said Ido Schoenberg, Chairman…
Amwell® Announces Results for the Second Quarter 2026
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the seco...